Cannabis Science, Inc.
| OTC Markets: CBIS
Cannabis Science, Inc. develops cannabis pharmaceutical products. It is at the forefront of cannabinoid research and development for unmet medical needs. The company works in HIV drug development, medicinal characterization, and clinical research to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. It is laying a solid foundation for entrance into the FDA and other government regulatory agencies for developing medicines for cancer, autism, Influenza, PTSD and other ailments. Cannabis Science was founded on February 29, 1996 and is headquartered in Colorado Springs, CO.